Transgenomic Sues Power3 for Libel, Slander, Breach of Contract in Protein Biomarker Deal

The lawsuit, filed this week in US District Court in Nebraska, stems from a deal signed last year to develop and commercialize Power3's biomarker tests for neurodegenerative diseases.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.